UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 318

Sortiert nach

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

Annals of oncology, 2021-05, Vol.32 (5), p.600-608

2021

Link zum Volltext

Verfügbarkeit prüfen

CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results

European journal of cancer (1990), 2020-10, Vol.138, p.172-181

2020

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study

Annals of oncology, 2019-07, Vol.30, p.iv126-iv126

2019

Link zum Volltext

Verfügbarkeit prüfen

Therapy susceptible germline-related BRCA 1-mutation in a case of metastasized mixed adeno-neuroendocrine carcinoma (MANEC) of the small bowel

BMC gastroenterology, 2018-05, Vol.18 (1), p.75-75, Article 75

2018

Link zum Volltext

Verfügbarkeit prüfen

Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group

ESMO open, 2024-04, Vol.9 (4), p.102944-102944, Article 102944

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

ESMO open, 2022-08, Vol.7 (4), p.100552-100552, Article 100552

2022

Link zum Volltext

Verfügbarkeit prüfen

Updated results from a phase II study of infigratinib (BGJ398), a selective pan-FGFR kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions

Annals of oncology, 2018-10, Vol.29, p.viii720-viii720

2018

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine plus afatinib versus gemcitabine alone in metastatic pancreatic cancer: An explorative randomized AIO phase II trial (ACCEPT)

Annals of oncology, 2018-10, Vol.29, p.viii243-viii243

2018

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology

Annals of oncology, 2005-08, Vol.16 (8), p.1381-1390

2005

Link zum Volltext

Verfügbarkeit prüfen

Rehabilitation of patients with acid-base and fluid balance disorders with short bowel syndrome after ileostomies

Die Rehabilitation, 2015-04, Vol.54 (2), p.86

2015

Link zum Volltext

Verfügbarkeit prüfen

O126 EVALUATION OF LY2157299 MONOHYDRATE (LY), A TGF-β RECEPTOR I KINASE INHIBITOR, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: PHASE 2 STUDY RESULTS OF SAFETY, EFFICACY AND PK/PD

Journal of hepatology, 2014-04, Vol.60 (1), p.S52-S53

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical management of chronic hepatitis B infection: results from a registry at a German tertiary referral center

Infection, 2015-04, Vol.43 (2), p.153-162

2015

Link zum Volltext

Verfügbarkeit prüfen

Interspecific and Intraspecific Interference of Palmer Amaranth (Amaranthus palmeri) and Large Crabgrass (Digitaria sanguinalis) in Sweetpotato

Weed science, 2019-07, Vol.67 (4), p.426-432

2019

Link zum Volltext

Verfügbarkeit prüfen

Der Weg zum Leberkrebszentrum: Versorgungs- und Patientenpfadanalyse für Patientinnen und Patienten mit hepatozellulärem Karzinom

Forum (Heidelberg), 2023-09, Vol.38 (4), p.269-273

2023

Link zum Volltext

Verfügbarkeit prüfen

SO-6 Changes in the course of advanced pancreatic cancer treatment with systemic chemotherapy: A pooled analysis of five clinical trials from two decades of clinical research within the German AIO Study-Group

Annals of oncology, 2023-06, Vol.34, p.S164-S164

2023

Link zum Volltext

Verfügbarkeit prüfen

Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation

Infection control and hospital epidemiology, 2002-05, Vol.23 (5), p.249

2002

Link zum Volltext

Verfügbarkeit prüfen

Effect of Bicyclopyrone on Triploid Watermelon in Plasticulture

Weed technology, 2018-08, Vol.32 (4), p.439-443

2018

Link zum Volltext

Verfügbarkeit prüfen

LBA37 IMMUTACE: A biomarker-orientated, multi center phase II AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC)

Annals of oncology, 2021-09, Vol.32, p.S1312-S1312

2021

Link zum Volltext

Verfügbarkeit prüfen

990P Updated results of a phase Ib study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2020-09, Vol.31, p.S691-S692

2020

Link zum Volltext

Verfügbarkeit prüfen

LBA10 Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer: Final results of the NIFE-trial (AIO-YMO HEP-0315), a randomized phase II study of the AIO biliary tract cancer group

Annals of oncology, 2021-09, Vol.32, p.S1282-S1282

2021

Link zum Volltext

Verfügbarkeit prüfen

1477P Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multi-agent induction chemotherapy: Results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

Annals of oncology, 2021-09, Vol.32, p.S1091-S1091

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 318

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(281)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Life Sciences & Biomedicine
(90)
Humans
(62)
Animals
(46)
Female
(40)
Biological And Medical Sciences
(37)
Male
(33)
Mice
(32)
Mathematics
(31)
Algebra
(23)
Physical Sciences
(23)
Medical Sciences
(20)
Algebraic Topology
(19)
Calculus & Mathematical Analysis
(19)
Immunology
(18)
Fundamental And Applied Biological Sciences. Psychology
(17)
Middle Aged
(17)
Adult
(14)
Medicine
(13)
B-Lymphocytes - Immunology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the ‘burden of therapy’ method

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group

CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results

Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study

Therapy susceptible germline-related BRCA 1-mutation in a case of metastasized mixed adeno-neuroendocrine carcinoma (MANEC) of the small bowel

Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group

Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

Updated results from a phase II study of infigratinib (BGJ398), a selective pan-FGFR kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions

Gemcitabine plus afatinib versus gemcitabine alone in metastatic pancreatic cancer: An explorative randomized AIO phase II trial (ACCEPT)

Corrigendum to “Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)”: [ESMO Open 7 (2024) 100552]

Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology

Rehabilitation of patients with acid-base and fluid balance disorders with short bowel syndrome after ileostomies

O126 EVALUATION OF LY2157299 MONOHYDRATE (LY), A TGF-β RECEPTOR I KINASE INHIBITOR, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: PHASE 2 STUDY RESULTS OF SAFETY, EFFICACY AND PK/PD

Clinical management of chronic hepatitis B infection: results from a registry at a German tertiary referral center

Interspecific and Intraspecific Interference of Palmer Amaranth (Amaranthus palmeri) and Large Crabgrass (Digitaria sanguinalis) in Sweetpotato

Der Weg zum Leberkrebszentrum: Versorgungs- und Patientenpfadanalyse für Patientinnen und Patienten mit hepatozellulärem Karzinom

SO-6 Changes in the course of advanced pancreatic cancer treatment with systemic chemotherapy: A pooled analysis of five clinical trials from two decades of clinical research within the German AIO Study-Group

Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation

Effect of Bicyclopyrone on Triploid Watermelon in Plasticulture

LBA37 IMMUTACE: A biomarker-orientated, multi center phase II AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC)

990P Updated results of a phase Ib study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC)

LBA10 Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer: Final results of the NIFE-trial (AIO-YMO HEP-0315), a randomized phase II study of the AIO biliary tract cancer group

1477P Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multi-agent induction chemotherapy: Results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

Ibrutinib in Combination with Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients with Metastatic Pancreatic Adenocarcinoma: Phase 3 RESOLVE Study

Suchergebnisse filtern